UK vape firm Plxsur sold for £76,500 after touting $1 billion revenue target

Jan.22
UK vape firm Plxsur sold for £76,500 after touting $1 billion revenue target
London-based vaping company Plxsur, which had claimed in fundraising materials it could reach $1 billion in annual revenue and capture about 10% of the global vaping market, has been sold out of administration for £76,500. Administrators said the figures were aspirational and depended on acquisitions that were never completed, as the company later ran out of cash and entered insolvency, with a shareholder ultimately buying the business.

Key points 

 

  • Plxsur was bought out of administration for £76,500 (about $97,000).
  • The company pitched a “roll-up and sell to Big Tobacco” strategy, but never exercised any of its 12 acquisition options.
  • In a March 2024 corporate presentation, Plxsur cited targets including ~10% global market share, $1 billion in revenue and over $200 million in earnings; administrators said the figures were aspirational and depended on acquisitions that did not happen.
  • Goldman Sachs worked on a sale but did not find a Big Tobacco buyer; Stifel later sought credit financing, also without success.
  • By late 2025, Plxsur had run short of cash, had no operating cash flow, and entered insolvency.

 

2Firsts, Jan. 22, 2026

 

According to Bloomberg News, UK vaping company Plxsur entered administration after failing to attract investment and running out of cash, before being bought out of the insolvency process for £76,500 (about $97,000), bringing its roll-up ambitions to an abrupt end.

 

Bloomberg cited documents from administrator KR8 Advisory Ltd. saying London-based Plxsur had signed 12 agreements that gave it the option to acquire vaping operations — including manufacturers in Latvia and the Czech Republic — but it ultimately did not complete any acquisitions.

 

Even so, Plxsur said in a March 2024 corporate presentation that it could secure about 10% of the global vaping market, lift annual revenue to $1 billion, and generate more than $200 million in earnings. KR8’s report said these figures were aspirational, reflecting the revenue scale Plxsur might have achieved if it had completed the acquisitions.

 

Bloomberg reported that Plxsur hired Goldman Sachs Group Inc. bankers to run a sale process, but failed to find a Big Tobacco buyer for the combined business. After that effort was paused, Plxsur selected Stifel Financial Corp. to seek credit investors willing to finance its acquisition strategy, but no deal materialised, according to people familiar with the matter.

 

Sources told Bloomberg that HPS Investment Partners came closest to providing a loan before walking away. A separate proposal later considered by investors led by New York-based private equity firm Cartesian Capital Group involved a roughly $90 million investment and a merger with a Nasdaq-listed SPAC, but that transaction also collapsed.

 

By late 2025, Plxsur’s cash position had deteriorated and, without operating cash flow or new capital injections in either equity or debt, the business fell into insolvency. KR8’s report said the buyer out of administration was James Cox, a Plxsur shareholder.

 

Bloomberg said a Goldman representative declined to comment, while Stifel, HPS and Cartesian did not respond to requests for comment.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s Department of Disease Control has warned the public not to believe claims that nicotine pouches are harmless, saying the products contain high levels of nicotine that can enter the bloodstream through the mouth lining and affect the nervous system and brain.
Apr.30 by 2FIRSTS.ai
Imperial Tobacco Canada Responds to Anti-Smoking Groups on Youth Vaping
Imperial Tobacco Canada Responds to Anti-Smoking Groups on Youth Vaping
Imperial Tobacco Canada responded to the April 17 press conference by anti-smoking groups by calling for a more focused, fact-based discussion on youth vaping that targets the illicit market. The company said youth should not be using nicotine products and that it supports strong measures to prevent youth access, but argued that the discussion failed to clearly distinguish between the regulated market and the illicit market that is driving youth access.
Apr.22 by 2FIRSTS.ai
Tobacco Farming in the New Nicotine Era: Why Indian Farmers Struggle to Transition — Contributed by Samrat Chowdhery
Tobacco Farming in the New Nicotine Era: Why Indian Farmers Struggle to Transition — Contributed by Samrat Chowdhery
In this contributed article to 2Firsts, Mumbai-based journalist and harm reduction advocate Samrat Chowdhery examines India’s tobacco transition from the perspective of agriculture, supply chains and regulation. As noted by 2Firsts, India offers a relevant case for understanding how new nicotine technologies may affect not only consumption, trade and policy, but also tobacco farming.
Special Report
May.29
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02
EU Launches Online Feedback as TPD Revision Enters New Milestone
EU Launches Online Feedback as TPD Revision Enters New Milestone
The European Commission has opened an online call for evidence on revising EU tobacco products and advertising rules, marking a new phase in the TPD/TAD review. Policy options may cover novel products, flavours, packaging, digital marketing and advertising. A 2Firsts review of 855 early submissions shows rapid engagement and recurring debate over differentiated regulation, harm reduction, youth protection, illicit trade and economic impact.
Special Report
May.21